Adenosine Deaminase Deficiency
Welcome,         Profile    Billing    Logout  
 0 Companies   0 Products   0 Products   0 Mechanisms of Action   1 Trial   4 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adenosine Deaminase Deficiency
NCT00547235: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

No Longer Available
N/A
US
therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation, total-body irradiation
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Infection, Precancerous/Nonmalignant Condition
12/12
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adenosine Deaminase Deficiency
NCT00547235: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

No Longer Available
N/A
US
therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation, total-body irradiation
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Infection, Precancerous/Nonmalignant Condition
12/12
 

Download Options